Chiron deal

Quarterly product sales grew to $50.1 million from $28.6 million, due to increased product sales from the Chiron Vision ophthalmic business, and $10.5 million in initial shipments of Betaseron (Interferon beta-1b)

Read the full 319 word article

How to gain access

Continue reading with a
two-week free trial.